Story
The Omega-6 : Omega-3 Balance
Last updated
In one pass Omega-6 and omega-3 fats are two families the human body cannot make and has to get from food, which is why they are called essential fatty acids.
Educational content, not medical advice — consult a clinician.
Story path
Chapter 1
Two essential fats
Omega-6 and omega-3 fats are two families the human body cannot make and has to get from food, which is why they are called essential fatty acids.
The bottleneck is two enzymes. Humans lack delta-12 desaturase and delta-15 desaturase, enzymes that add double bonds to a fatty acid's carbon chain, so we cannot place a double bond at the sixth or the third carbon from the chain's far end (the methyl end). That is exactly what the names omega-6 and omega-3 describe: whether the first double bond sits at carbon 6 or at carbon 3 counted from that end. Both families are polyunsaturated fatty acids (), fats with two or more double bonds in the chain.
So how much of either raw material your body has depends on which oils you use and whether you eat nuts and fish. And the two families do not run on separate tracks inside you; they compete for the same set of enzymes that process them.
The bottleneck is two enzymes. Humans lack delta-12 desaturase and delta-15 desaturase, enzymes that add double bonds to a fatty acid's carbon chain, so we cannot place a double bond at the sixth or the third carbon from the chain's far end (the methyl end). That is exactly what the names omega-6 and omega-3 describe: whether the first double bond sits at carbon 6 or at carbon 3 counted from that end. Both families are polyunsaturated fatty acids (), fats with two or more double bonds in the chain.
So how much of either raw material your body has depends on which oils you use and whether you eat nuts and fish. And the two families do not run on separate tracks inside you; they compete for the same set of enzymes that process them.
Mechanism · From food to the long-chain products
Many people hear that omega-3 is good and reach straight for more fish oil. Fixing on one thing frames the problem too narrowly: what actually gets built into cell membranes and turned into signals depends on how the two families are paired and where they come from.The omega-6 family starts with linoleic acid (LA; 18:2, meaning 18 carbons and 2 double bonds), found in soybean, corn and sunflower oil and in nuts. The omega-3 family starts with the plant fat alpha-linolenic acid (; 18:3), found in flaxseed, chia seeds and walnuts. The two differ only in how far the first double bond sits from the methyl end.
The liver takes both chains further, lengthening them and adding double bonds. Downstream on the omega-3 side are and , the two long-chain omega-3 fats in fish oil; DHA is also one of the main building materials of brain and retina cell membranes. Downstream on the omega-6 side is arachidonic acid (AA). Humans cannot make the two starting molecules, but can make some of the downstream products themselves, provided the shared processing enzymes are not already taken up by the other family.
Chapter 3
Built into membranes and signals
Omega-6 and omega-3 fats do their real work in cell membranes: over time, the makeup of the membrane shifts toward whatever you have been eating.
The membrane around every cell is made of two layers of phospholipids (the phospholipid bilayer), and linoleic acid and arachidonic acid (the omega-6 family), as well as and (the omega-3 family), are all built into it; turnover takes weeks to months. When a cell is stimulated, an enzyme called phospholipase A2 snips a fatty acid off the membrane and turns it into eicosanoids, short-lived but potent local signaling molecules made from twenty-carbon fatty acids. Prostaglandins and leukotrienes belong to this group, and they govern inflammation, the narrowing of blood vessels and the clumping of platelets. Which fatty acid gets snipped off sets the character of the signal that comes out.
So diet changes not just a passing number in the blood but the raw material your cells use to make signals.
The membrane around every cell is made of two layers of phospholipids (the phospholipid bilayer), and linoleic acid and arachidonic acid (the omega-6 family), as well as and (the omega-3 family), are all built into it; turnover takes weeks to months. When a cell is stimulated, an enzyme called phospholipase A2 snips a fatty acid off the membrane and turns it into eicosanoids, short-lived but potent local signaling molecules made from twenty-carbon fatty acids. Prostaglandins and leukotrienes belong to this group, and they govern inflammation, the narrowing of blood vessels and the clumping of platelets. Which fatty acid gets snipped off sets the character of the signal that comes out.
So diet changes not just a passing number in the blood but the raw material your cells use to make signals.
Mechanism · Why arachidonic acid is not simply a villain
Starting from arachidonic acid (AA, a downstream product of omega-6), the body mostly makes signals with stronger pro-inflammatory effects (series-2 prostaglandins and series-4 leukotrienes). Starting from (one of the long-chain omega-3 fats in fish oil), it makes counterparts of the same kind that are much less inflammatory, and EPA and can also be turned into resolvins, molecules that actively call off inflammation and help tissue wrap up. Know the limits here: the resolvin pathway has been worked out mainly in animal and cell experiments (Serhan 2014), and how much it does in people has not been measured. By the mechanism, the value of omega-3 is not simply being anti-inflammatory; it lights a little less fire and keeps a little more capacity on hand to close inflammation down.Filing arachidonic acid away as the culprit behind inflammation gets it wrong. The reality is subtler:
AA really is the raw material for many pro-inflammatory prostaglandins and leukotrienes, but it is also the raw material for lipoxins, which are anti-inflammatory. The body uses the same fatty acid to light the fire and to put it out, switching by timing and by enzyme.AA is also a normal structural part of brain and muscle cell membranes, and infant formula often adds AA together with DHA. With no AA at all, the body runs into problems too.Inflammation itself is not bad; it is a necessary part of repair and of fighting infection. The real problem is inflammation that does not resolve when it should and drags on as low-grade chronic inflammation.
So the more accurate framing is not to eliminate omega-6 or AA but to make sure the absolute amount of omega-3 (EPA and DHA) is enough, so inflammation has enough molecules on hand to close it out. That is why, by the mechanism, raising the absolute amount of omega-3 stands on firmer ground than fighting over the omega-6 ratio. This is mechanistic reasoning, not a conclusion that trials have compared directly.
Chapter 4
The debate over an ideal ratio
Pushing the omega-6 to omega-3 ratio down to some ideal (4:1 is the figure you usually hear, or even 1:1) is a target that lacks support from hard-outcome evidence in people and is still contested. When the European Food Safety Authority (EFSA) assessed dietary fats in 2010, it explicitly decided not to set a reference value for this ratio and gave separate absolute intakes instead.
The idea comes from the ratio hypothesis of the 1990–2000s, advanced most influentially in a narrative review by Simopoulos. She estimated that ancestral human diets had an omega-6 to omega-3 ratio of about 1:1, against 15:1 to nearly 17:1 in modern Western diets, and argued for bringing the ratio down to between 1:1 and 4:1. This is expert opinion, not a trial result.
It makes mechanistic sense (the two families compete for the same enzymes), and it did remind people that omega-3 intake is commonly too low. But treating 4:1 or 1:1 as a hard target does not hold up in the human evidence: the ratio is a way of thinking about the problem, not an operating target that authorities recommend.
The idea comes from the ratio hypothesis of the 1990–2000s, advanced most influentially in a narrative review by Simopoulos. She estimated that ancestral human diets had an omega-6 to omega-3 ratio of about 1:1, against 15:1 to nearly 17:1 in modern Western diets, and argued for bringing the ratio down to between 1:1 and 4:1. This is expert opinion, not a trial result.
It makes mechanistic sense (the two families compete for the same enzymes), and it did remind people that omega-3 intake is commonly too low. But treating 4:1 or 1:1 as a hard target does not hold up in the human evidence: the ratio is a way of thinking about the problem, not an operating target that authorities recommend.
Evidence · Why the ratio is hard to pin down
What EFSA gave instead were separate adequate intakes (, reference values set when the evidence is not strong enough for a recommended intake): linoleic acid at about 4% of total energy, alpha-linolenic acid () at about 0.5%, and 250 mg a day of and combined for adults. None of them is a ratio you are supposed to hit.The ratio hypothesis is contested for several concrete reasons:
1. The ancestral 1:1 is an estimate, not a measurement. The fatty-acid makeup of Paleolithic diets can only be inferred, and different studies give widely different ancient ratios, so treating it as a precise baseline is shaky from the start.
2. The same ratio can be built from completely different absolute amounts. A 5:1 ratio can mean both are very low or both are very high, and those mean completely different things for the body. Looking only at the ratio erases that layer.
3. Human hard-outcome evidence does not support making the ratio the target. For outcomes such as cardiovascular events and death, the 2011 review by Mozaffarian and Wu found the benefit most consistent for long-chain omega-3 itself: in prospective observational studies and adequately powered randomized trials, it was linked to fewer coronary heart disease deaths and sudden cardiac deaths, not to any particular ratio. In the other direction, there is no human evidence that pushing omega-6 down helps: in healthy people, adding linoleic acid did not worsen inflammatory markers or cardiovascular events, and the trial details are in the later chapter on whether seed oils inflame.
So EFSA's approach works as a yardstick for claims like this: getting enough omega-3 in absolute terms (especially EPA and DHA) is a step with evidence behind it; chasing a fixed ratio is a contested, secondary goal. Honestly, this field has no settled answer yet.
Chapter 5
Do seed oils inflame?
The claim that seed oils (soybean, corn and sunflower oil) are rich in omega-6 and therefore inflame the whole body has not held up in human trials. The reasoning runs from omega-6 to arachidonic acid, and from arachidonic acid to pro-inflammatory signals. Each link sounds plausible on its own, but the chain stalls at the last step: when people actually eat more, the inflammatory markers in their blood do not move.
A 2012 systematic review by Johnson and Fritsche pooled 15 in healthy adults: changing how much linoleic acid (LA, the starting point of omega-6) people ate produced virtually no change in blood markers of inflammation. The reason goes back to the processing line: only a small fraction of linoleic acid is converted into arachidonic acid, so eating more of it does not proportionally raise arachidonic acid in tissues.
A 2009 science advisory from the American Heart Association (AHA) concluded that omega-6 polyunsaturated fat at 5%–10% of energy or more benefits coronary heart disease risk rather than harming it. Where seed oils do deserve care is in how they are used.
A 2012 systematic review by Johnson and Fritsche pooled 15 in healthy adults: changing how much linoleic acid (LA, the starting point of omega-6) people ate produced virtually no change in blood markers of inflammation. The reason goes back to the processing line: only a small fraction of linoleic acid is converted into arachidonic acid, so eating more of it does not proportionally raise arachidonic acid in tissues.
A 2009 science advisory from the American Heart Association (AHA) concluded that omega-6 polyunsaturated fat at 5%–10% of energy or more benefits coronary heart disease risk rather than harming it. Where seed oils do deserve care is in how they are used.
Evidence · Where seed oils really go wrong
In the Johnson and Fritsche review, C-reactive protein (, a protein the liver pours out during inflammation), fibrinogen, various cytokines and (a pro-inflammatory cytokine) showed virtually no change. Cardiovascular endpoints send the same signal. A 2010 of by Mozaffarian found that replacing saturated fat with polyunsaturated fat lowered coronary heart disease events by about 19% in relative terms; that polyunsaturated fat included both omega-6 and omega-3. A 2018 Cochrane systematic review of omega-6 on its own concluded that increasing omega-6 makes little or no difference to cardiovascular events and deaths, with a possible small reduction in heart attacks (low-certainty evidence). That is hardly harmful.The opposite mistake, waving away every concern about seed oils in one line, is also wrong. The more accurate move is to separate two things:
The molecule itself (linoleic acid): in randomized trials in healthy people, simply eating more linoleic acid did not raise inflammatory markers or increase cardiovascular events. At this level, the inflammation claim has no support from human evidence.
How these oils get used: two situations really deserve caution.
Old oil used again and again for deep-frying: polyunsaturated fats have many double bonds and oxidize easily, and repeated high heat produces oxidation products such as aldehydes. Those products are what deserve concern, and the reason is the many easily oxidized double bonds, not linoleic acid's identity as an omega-6.Carriers in ultra-processed food: a lot of refined seed oil ends up in chips, cookies and fast food. The bill for these foods belongs to ultra-processing and high energy density as a whole, and cannot simply be handed to omega-6.
So the practical conclusion is not to treat seed oil as poison. It is this: for everyday cooking, prefer oils that are more stable against oxidation, such as olive oil and avocado oil; eat less food that has been deep-fried repeatedly; eat less ultra-processed food. As for inflammation, the mechanism suggests that getting enough omega-3 makes more sense than cutting omega-6 to zero. Seed-oil oxidation and the wider diet are covered in more depth in two other stories, Seed Oils and Chronic low-grade inflammation.
Chapter 6
Get enough omega-3 first
Get enough long-chain omega-3 first, and prefer taking and (the two long-chain omega-3 fats in fish oil) directly from food; flaxseed is not the equivalent of fish.
Flaxseed, chia seeds and walnuts provide the plant omega-3 alpha-linolenic acid (). It still has to compete with omega-6 for delta-6 desaturase, and the amount that becomes EPA and DHA cannot cover what you need. Fatty fish such as salmon, sardines, herring and mackerel, or algae oil for vegetarians, deliver EPA and DHA straight into cell membranes.
Omega-6 is still essential and does not need to be treated as an enemy. Once the bottom of the fraction (omega-3) is filled, the ratio comes down on its own. If you take anticoagulants or are preparing for surgery, ask a doctor before taking high-dose omega-3 supplements.
Flaxseed, chia seeds and walnuts provide the plant omega-3 alpha-linolenic acid (). It still has to compete with omega-6 for delta-6 desaturase, and the amount that becomes EPA and DHA cannot cover what you need. Fatty fish such as salmon, sardines, herring and mackerel, or algae oil for vegetarians, deliver EPA and DHA straight into cell membranes.
Omega-6 is still essential and does not need to be treated as an enemy. Once the bottom of the fraction (omega-3) is filled, the ratio comes down on its own. If you take anticoagulants or are preparing for surgery, ask a doctor before taking high-dose omega-3 supplements.
In practice · Get enough EPA and DHA first
Brought down to what you can do each day, it comes to three things:1. First, raise the absolute amount of omega-3. EFSA's adequate intake for adults is 250 mg a day of and combined. National and international guidelines broadly converge on at least 250 mg a day of long-chain omega-3, or at least 2 servings of fatty fish a week (salmon, sardines, herring, mackerel), as the 2011 review by Mozaffarian and Wu summarizes. Vegetarians can take DHA directly from algae oil. Flaxseed supplies alpha-linolenic acid () and cannot stand in for that amount.
2. Don't fight over a ratio, and don't treat omega-6 as the enemy. Omega-6 is an essential fatty acid, and avoiding it entirely causes problems of its own. Rather than battling the ratio, fill in the bottom of the fraction (omega-3), and the ratio comes down by itself.
3. Oils and cooking methods deserve more attention than the omega numbers. Use olive oil and avocado oil as everyday cooking oils, and eat less food fried repeatedly at high heat and less ultra-processed food. Each of these has its own reason (fewer oxidation products, less ultra-processed food) and does not depend on the ratio hypothesis being right.
To read on: Fats & Omega-3 gives the overall picture of fats, Fish Oil · EPA / DHA Supplement covers choosing a supplement, and Seed Oils and Chronic low-grade inflammation continue with oil oxidation and the wider diet.
Safety · Who should check with a doctor first
If you take anticoagulants, are preparing for surgery, or have particular metabolic or cardiovascular conditions, check with a doctor before taking high-dose omega-3 supplements.This is general information, not medical advice.
References · 14
- Institute of Medicine. (2005). Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. National Academies Press. nap.nationalacademies.org/catalog/10490/dietary-reference-intakes-for-energy-carbohydrate-fiber-fat-fatty-acids-cholesterol-protein-and-amino-acids
- National Institutes of Health, Office of Dietary Supplements. (2023). Omega-3 Fatty Acids — Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional
- Burdge, G. C. (2006). Metabolism of α-linolenic acid in humans. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75(3), 161–168. Conversion of dietary ALA is limited; the 2002 young-women / young-men tracer papers are different studies (EPA ~21% / DHA ~9% in women; little DHA enrichment in men) and are not this record. 10.1016/j.plefa.2006.05.013
- Burdge, G. C., & Calder, P. C. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction, Nutrition, Development, 45(5), 581-597. Conversion of dietary ALA to EPA is limited (~5-10%) and conversion to DHA is very low (often <1%), so plant ALA cannot substitute for the EPA/DHA in fish. 10.1051/rnd:2005047
- Blasbalg, T. L., Hibbeln, J. R., Ramsden, C. E., Majchrzak, S. F., & Rawlings, R. R. (2011). Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. The American Journal of Clinical Nutrition, 93(5), 950-962. Apparent linoleic acid intake rose substantially across the 20th century, primarily from soybean oil. US food-disappearance data 1909-1999: soybean oil consumption rose more than 1000-fold; linoleic acid availability rose from 2.79% to 7.21% of energy and ALA from 0.39% to 0.72%; the LA:ALA ratio rose from 6.4 to 10.0; estimated omega-3 index fell from 6.51-8.28 to 3.84 (abstract, PMID 21367944). 10.3945/ajcn.110.006643
- Mozaffarian, D., & Wu, J. H. Y. (2011). Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology, 58(20), 2047–2067. 10.1016/j.jacc.2011.06.063
- Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503), 92-101. Specialized pro-resolving mediators (resolvins, protectins, maresins) derived from the omega-3 fatty acids EPA and DHA actively drive the resolution of acute inflammation; mechanisms established largely in animal and in-vitro models. 10.1038/nature13479
- Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56(8), 365-379. A narrative/evolutionary review proposing that an ancestral n-6:n-3 ratio near 1:1 (vs. ~15-17:1 in Western diets) and a target ratio of 1:1 to 4:1 are protective — the seminal but contested 'ratio hypothesis'. 10.1016/S0753-3322(02)00253-6
- EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). (2010). Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal, 8(3), 1461. The Panel proposed not to set a Dietary Reference Value for the n-3/n-6 ratio, instead setting Adequate Intakes for linoleic acid (4% of energy), α-linolenic acid (0.5% of energy), and EPA+DHA (250 mg/day for adults). 10.2903/j.efsa.2010.1461
- Johnson, G. H., & Fritsche, K. (2012). Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. Journal of the Academy of Nutrition and Dietetics, 112(7), 1029-1041. Across 15 RCTs in healthy non-infant adults, altering dietary linoleic acid produced virtually no change in inflammatory markers (CRP, fibrinogen, PAI-1, cytokines, soluble adhesion molecules, TNF-α). 10.1016/j.jand.2012.03.029
- Harris, W. S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L. L., Appel, L. J., et al. (2009). Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation, 119(6), 902-907. The AHA advises that omega-6 PUFA intake of at least 5-10% of energy is beneficial (not harmful) for coronary heart disease risk in the context of recommended dietary patterns. 10.1161/CIRCULATIONAHA.108.191627
- Mozaffarian, D., Micha, R., & Wallace, S. (2010). Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Medicine, 7(3), e1000252. Replacing saturated fat with polyunsaturated fat reduced CHD events ~19% (RR 0.81, 95% CI 0.70-0.95), ~10% per 5% energy. 10.1371/journal.pmed.1000252
- Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., et al. (2018). Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, (11), CD011094. Increasing omega-6 fats made little or no difference to cardiovascular events or mortality (low-certainty evidence), with a possible small reduction in myocardial infarction. 10.1002/14651858.CD011094.pub3
- Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., et al. (2017). Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association. Circulation, 136(3), e1-e23. Coconut oil is ~82% saturated; the AHA advises against its use because it raises LDL-C with no known offsetting favorable effect, and recommends replacing saturated with unsaturated fat. 10.1161/CIR.0000000000000510